Volume 53, Issue 2 pp. 495-498

Concurrent Detection of Heroin, Fentanyl, and Xylazine in Seven Drug-related Deaths Reported from the Philadelphia Medical Examiner’s Office

Stella C. Wong D.O.

Stella C. Wong D.O.

Department of Emergency Medicine, Nazareth Hospital, Philadelphia, PA.

Search for more papers by this author
John A. Curtis M.D.

John A. Curtis M.D.

Department of Emergency Medicine, Nazareth Hospital, Philadelphia, PA.

Search for more papers by this author
William E. Wingert Ph.D.

William E. Wingert Ph.D.

The Philadelphia Medical Examiner’s Office, Philadelphia, PA.

Search for more papers by this author
First published: 16 February 2008
Citations: 70
Additional information and reprint requests:
Stella C. Wong, D.O.
Department of Emergency Medicine
Nazareth Hospital
2601 Holme Avenue
Philadelphia, PA
E-mail: [email protected]

We have not presented this article in other meetings or literature. However, we presented a poster of our findings at the North American Congress of Clinical Toxicology (NACCT) meeting in October 2007

Abstract

Abstract: Recreational drugs, such as cocaine and heroin, are often adulterated with other pharmacological agents to either enhance or diminish the drug effects. Between April 21, 2006 and August 8, 2006, the Philadelphia Medical Examiner’s Office detected xylazine (a veterinary sedative) and fentanyl (a synthetic opioid) in specimens taken from seven cases. Initial immunoassay screening was performed on urine and blood for fentanyl, opiate, cocaine, phencyclidine (PCP), and benzodiazepines. All tests reported positive were confirmed by gas chromatography-mass spectrometry. All seven xylazine positive cases tested positive for fentanyl and six cases tested positive for 6-acetylmorphine (a metabolite and definitive marker for heroin). The seventh case was positive for morphine and had a history of heroin abuse. Xylazine was present in urine in all seven cases and blood levels were detected in three cases. The blood concentrations ranged from trace to 130 ng/mL. Fentanyl was present in the blood and urine in each case and blood concentrations ranged from 4.7 to 47 ng/mL. Adulteration of illicit drugs has become an epidemic health concern for drug users. Healthcare professionals need to be aware of this issue, so the patients can be treated in an effective, timely manner.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.